Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.
AmpD indirectly regulates the production of AmpC beta-lactamase via the cell wall recycling pathway. Recent publications have demonstrated the presence of multiple ampD genes in Pseudomonas aeruginosa and Escherichia coli. In the prototype P. aeruginosa strain, PAO1, the three ampD genes (ampD, ampDh2, and ampDh3) contribute to a stepwise regulation of ampC beta-lactamase and help explain the partial versus full derepression of ampC. In the present study, the roles of the three ampD homologs in nine clinical P. aeruginosa isolates with either partial or full derepression of ampC were evaluated. In eight of nine isolates, decreased RNA expression of the ampD genes was not associated with an increase in ampC expression. Sequence analyses revealed that every derepressed isolate carried mutations in ampD, and in two fully derepressed strains, only ampD was mutated. Furthermore, every ampDh2 gene was of the wild type, and in some fully derepressed isolates, ampDh3 was also of the wild type. Mutations in ampD and ampDh3 were tested for their effect on function by using a plasmid model system, and the observed mutations resulted in nonfunctional AmpD proteins. Therefore, although the sequential deletion of the ampD homologs of P. aeruginosa can explain partial and full derepression in PAO1, the same model does not explain the overproduction of AmpC observed in these clinical isolates. Overall, the findings of the present study indicate that there is still an unknown factor(s) that contributes to ampC regulation in P. aeruginosa.
Schmidtke
Amber J
AJ
Department of Medical Microbiology and Immunology, Center for Research in Anti-Infectives and Biotechnology, Creighton University, Omaha, Nebraska 68178, USA.
Hanson
Nancy D
ND
D000595:Amino Acid Sequence; D001426:Bacterial Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism*; D001483:Base Sequence; D017931:DNA Primers / Q000235:genetics; D004269:DNA, Bacterial / Q000235:genetics; D015964:Gene Expression Regulation, Bacterial; D015971:Gene Expression Regulation, Enzymologic; D005798:Genes, Bacterial; D005816:Genetic Complementation Test; D006801:Humans; D008969:Molecular Sequence Data; D009238:N-Acetylmuramoyl-L-alanine Amidase / Q000235:genetics / Q000378:metabolism*; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics* / Q000302:isolation & purification; D012329:RNA, Bacterial / Q000235:genetics / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D018440:beta-Lactam Resistance / Q000235:genetics; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics
D001426:Bacterial Proteins; D017931:DNA Primers; D004269:DNA, Bacterial; D012329:RNA, Bacterial; C071526:AmpR protein, Bacteria; C062460:AmpD protein, Bacteria; D009238:N-Acetylmuramoyl-L-alanine Amidase; C048795:AmpC beta-lactamases; D001618:beta-Lactamases
Antimicrob Agents Chemother. 2006 Jun;50(6):2030-7
16723562
Antimicrob Agents Chemother. 2002 Nov;46(11):3406-11
12384343
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
12136088
Genome Res. 2005 Feb;15(2):321-9
15687295
Antimicrob Agents Chemother. 1998 Jun;42(6):1350-4
9624474
Clin Microbiol Infect. 2007 Apr;13(4):413-8
17359326
Antimicrob Agents Chemother. 1986 Sep;30(3):453-7
3096196
Antimicrob Agents Chemother. 2006 May;50(5):1633-41
16641429
Methods. 2001 Dec;25(4):402-8
11846609
Antimicrob Agents Chemother. 2006 May;50(5):1780-7
16641450
Antimicrob Agents Chemother. 1995 Nov;39(11):2494-8
8585732
J Antimicrob Chemother. 2003 May;51(5):1141-51
12697654
Antimicrob Agents Chemother. 2007 Aug;51(8):2997-3000
17517839
J Gen Microbiol. 1977 Apr;99(2):263-76
327021
Antimicrob Agents Chemother. 2005 Nov;49(11):4763-6
16251325
Antimicrob Agents Chemother. 1997 Jun;41(6):1380-4
9174204
J Bacteriol. 2007 Aug;189(15):5634-41
17526703
Protein Sci. 2003 Aug;12(8):1652-62
12876315
Antimicrob Agents Chemother. 2000 Mar;44(3):583-9
10681322
Curr Pharm Des. 1999 Nov;5(11):881-94
10539994